Induction of rat liver cytochrome P450 isoenzymes CYP 1A and CYP 2B by different fungicides, nitrofurans, and quercetinRAHDEN-STARON, Iwonna; CZECZOT, Hanna; SZUMILO, Maria et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2001, Vol 498, Num 1-2, pp 57-66, issn 1383-5718Article

Assessment of CYP1A2 activity in clinical practice : Why, how, and when?FABER, Mirko S; JETTER, Alexander; FUHR, Uwe et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 97, Num 3, pp 125-134, issn 1742-7835, 10 p.Article

Low CYP1A2 activity associated with testicular cancerVISTISEN, Kirsten; LOFT, Steffen; OLSEN, Jørgen H et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 6, pp 923-929, issn 0143-3334, 7 p.Article

The stimulatory role of human cytochrome b₅ in the bioactivation activities of human CYP1A2, 2A6 and 2E1 : a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100)DUARTE, Maria Paula; BRITO PALMA, Bernardo; GILEP, Andrei A et al.Mutagenesis. 2007, Vol 22, Num 1, pp 75-81, issn 0267-8357, 7 p.Article

INHIBITEURS ET SUBSTRATS DE L'ISOENZYME CYP 1A2 du CYTOCHROME P450 = Inhibitors and substrates of CYP1A2 isozymeLa Revue Prescrire. 2007, Vol 27, Num 290, pp 199-199, issn 0247-7750, 1 p., SUPArticle

Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletineLABBE, L; ABOLFATHI, Z; LESSARD, E et al.Xenobiotica (London. Print). 2003, Vol 33, Num 1, pp 13-25, issn 0049-8254, 13 p.Article

Sequence variants at CYP1A1―CYP1A2 and AHR associate with coffee consumptionSULEM, Patrick; GUDBJARTSSON, Daniel F; MÄGI, Reedik et al.Human molecular genetics (Print). 2011, Vol 20, Num 10, pp 2071-2077, issn 0964-6906, 7 p.Article

The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1 : a new cell expression system to study cytochrome P450 mediated biotransformationDUARTE, Maria Paula; BRITO PALMA, Bernardo; GILEP, Andrei A et al.Mutagenesis. 2005, Vol 20, Num 2, pp 93-100, issn 0267-8357, 8 p.Article

Functional analysis of three CYP1A2 variants found in a Japanese populationSAITO, Yoshiro; HANIOKA, Nobumitsu; NARIMATSU, Shizuo et al.Drug metabolism and disposition. 2005, Vol 33, Num 12, pp 1905-1910, issn 0090-9556, 6 p.Article

Consumption of charcoal-broiled meat as an experimental tool for discerning CYP1A2-mediated drug metabolism in vivoLARSEN, John Teilmann; BROSEN, Kim.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 97, Num 3, pp 141-148, issn 1742-7835, 8 p.Article

Time response of cytochrome P450 1A2 activity on cessation of heavy smokingFABER, Mirko S; FUHR, Uwe.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 2, pp 178-184, issn 0009-9236, 7 p.Article

Inhibition of human CYP1A2 activity in vitro by methylxanthines : Potent competitive inhibition by 8-phenyltheophyllineMURRAY, S; ODUPITAN, A. O. A; MURRAY, B. P et al.Xenobiotica (London. Print). 2001, Vol 31, Num 3, pp 135-151, issn 0049-8254Article

Simultaneous assessment of CYP3A4 and CYP1A2 activity in vivo with alprazolam and caffeineSCHMIDER, J; BROCKMÖLLER, J; AROLD, G et al.Pharmacogenetics (London). 1999, Vol 9, Num 6, pp 725-734, issn 0960-314XArticle

The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapineEIERMANN, B; ENGEL, G; JOHANSSON, I et al.British journal of clinical pharmacology. 1997, Vol 44, Num 5, pp 439-446, issn 0306-5251Article

PharmGKB summary: very important pharmacogene information for CYP1A2THORN, Caroline F; AKLILLU, Eleni; KLEIN, Teri E et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 1, pp 73-77, issn 1744-6872, 5 p.Article

Inhibiteurs et substrats de l'isoenzyme CYP 1A2 du cytochrome P450 = Inhibitors and substrates of the isozyme CYP1A2 of cytochrome P450La Revue Prescrire. 2008, Vol 28, Num DEC, pp 275-275, issn 0247-7750, 1 p., SUPArticle

Characterization of the inhibition of P4501A2 by furafyllineCLARKE, S. E; AYRTON, A. D; CHENERY, R. J et al.Xenobiotica (London. Print). 1994, Vol 24, Num 6, pp 517-526, issn 0049-8254Article

Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptanWILD, M. J; MCKILLOP, D; BUTTERS, C. J et al.Xenobiotica (London. Print). 1999, Vol 29, Num 8, pp 847-857, issn 0049-8254Article

Comparative inhibition of human cytochromes P450 1a1 and 1A2 by flavonoidsSUOPING ZHAI; RENKE DAI; FRIEDMAN, F. K et al.Drug metabolism and disposition. 1998, Vol 26, Num 10, pp 989-992, issn 0090-9556Article

Autoactivation and activation of the cytochrome P450sEKINS, S; RING, B. J; BINKLEY, S. N et al.International journal of clinical pharmacology and therapeutics. 1998, Vol 36, Num 12, pp 642-651, issn 0946-1965Article

Metabolism of [3-¹⁴C] coumarin by human liver microsomesVAN IERSEL, M. L. P. S; HENDERSON, C. J; WALTERS, D. G et al.Xenobiotica (London. Print). 1994, Vol 24, Num 8, pp 795-803, issn 0049-8254Article

Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitroGRANFORS, Marika T; BACKMAN, Janne T; LAITILA, Jouko et al.British journal of clinical pharmacology. 2004, Vol 57, Num 3, pp 349-353, issn 0306-5251, 5 p.Article

Identification of cytochrome P450 isoform involved in the metabolism of YM992, a novel selective serotonin re-uptake inhibitor, in human liver microsomesNOGUCHI, K; MERA, A; WATANABE, T et al.Xenobiotica (London. Print). 2000, Vol 30, Num 5, pp 503-513, issn 0049-8254Article

Pharmacogenetics of P450 oxidoreductase : effect of sequence variants on activities of CYP1A2 and CYP2C19AGRAWAL, Vishal; NINGWU HUANG; MILLER, Walter L et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 7, pp 569-576, issn 1744-6872, 8 p.Article

Genetic polymorphism of cytochrome P450s in beagles : possible influence of CYP1A2 deficiency on toxicological evaluationsKAMIMURA, H.Archives of toxicology. 2006, Vol 80, Num 11, pp 732-738, issn 0340-5761, 7 p.Article